BBC journalist Graham Easton investigates the future of drug trials following the events of trial TGN1412.The BBC interviewer talks to Professor Gordon Duff (Commission on Human Medicines), Professor Andre Mclean (Imperial College London), Dr Jörg Täubel (Richmond Pharmacology), Professor Terry Hamblin (University of Southampton), Dr Ganesh Suntharalingam (Northwick Park Hospital), Professor Deborah Saltman (BioMedical Central), Dr Elaine Godfrey (MHRA), and Dr Mark Lewis (Strategic Health Authority), to get their opinion leading analysis of the event and the future of drug trials, covering:

  • What can be learnt and changed from the incident?
  • Should all first in man trials be conducted in a Hospital setting?
  • Regulatory issues

Click here to read the transcript

Latest news

Richmond Pharmacology Establishes Expert Regulatory Advisory Board

February 12, 2026
Richmond Pharmacology, a leading clinical research organisation specialising in early-phase and innovative clinical trials
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event